Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

sandoz s.r.o., praha array - 17180 lenalidomid - tvrdá tobolka - 25mg - lenalidomid

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

sandoz s.r.o., praha array - 17180 lenalidomid - tvrdá tobolka - 5mg - lenalidomid

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

teva b.v., haarlem array - 21458 monohydrÁt lenalidomid-hydrochloridu - tvrdá tobolka - 10mg - lenalidomid

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

teva b.v., haarlem array - 21458 monohydrÁt lenalidomid-hydrochloridu - tvrdá tobolka - 15mg - lenalidomid

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

teva b.v., haarlem array - 21458 monohydrÁt lenalidomid-hydrochloridu - tvrdá tobolka - 25mg - lenalidomid

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

teva b.v., haarlem array - 21458 monohydrÁt lenalidomid-hydrochloridu - tvrdá tobolka - 5mg - lenalidomid

Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

accord healthcare s.l.u. - lenalidomid - mnohočetný myelom - imunosupresiva - multiple myelomalenalidomide accord as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide accord as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indikován k léčbě dospělých pacientů s dříve neléčeným mnohočetným myelomem, kteří nejsou způsobilí pro transplantaci. lenalidomid accord v kombinaci s dexamethasonem je indikován k léčbě mnohočetného myelomu u dospělých pacientů, kteří absolvovali alespoň jednu předchozí terapii. follicular lymphomalenalidomide accord in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

mylan ireland limited - lenalidomid - mnohočetný myelom - imunosupresiva - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

stada arzneimittel ag, bad vilbel array - 17180 lenalidomid - tvrdá tobolka - 10mg - lenalidomid

Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

stada arzneimittel ag, bad vilbel array - 17180 lenalidomid - tvrdá tobolka - 15mg - lenalidomid